KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Cost of Revenue: 2020-2024

Historic Cost of Revenue for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Dec 2024 value amounting to $38.5 million.

  • Ginkgo Bioworks Holdings' Cost of Revenue fell 18.12% to $8.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.1 million, marking a year-over-year increase of 9.97%. This contributed to the annual value of $38.5 million for FY2024, which is 17.14% down from last year.
  • Latest data reveals that Ginkgo Bioworks Holdings reported Cost of Revenue of $38.5 million as of FY2024, which was down 17.14% from $46.5 million recorded in FY2023.
  • In the past 5 years, Ginkgo Bioworks Holdings' Cost of Revenue registered a high of $183.6 million during FY2022, and its lowest value of $8.9 million during FY2020.
  • Over the past 3 years, Ginkgo Bioworks Holdings' median Cost of Revenue value was $46.5 million (recorded in 2023), while the average stood at $89.5 million.
  • Its Cost of Revenue has fluctuated over the past 5 years, first skyrocketed by 1,356.21% in 2021, then tumbled by 74.66% in 2023.
  • Yearly analysis of 5 years shows Ginkgo Bioworks Holdings' Cost of Revenue stood at $8.9 million in 2020, then soared by 1,356.21% to $129.7 million in 2021, then soared by 41.55% to $183.6 million in 2022, then slumped by 74.66% to $46.5 million in 2023, then decreased by 17.14% to $38.5 million in 2024.